Progressive polyradiculoneuropathy in diabetes: Correlation of variables and clinical outcome after immunotherapy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 5, 1999, Pages 607-612

  Jaradeh, Safwan S ^a   Prieto, Thomas E ^a   Lobeck, Lorri J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diabetes mellitus; Immunosuppressive treatment; Peripheral nerve diseases; Polyradiculoneuropathy

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR REFLEX; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMYELINATION; DIABETES MELLITUS; DISEASE DURATION; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INFLAMMATORY INFILTRATE; MALE; MOTOR DYSFUNCTION; NERVE BIOPSY; NERVE FIBER; NERVE FIBER DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMAPHERESIS; POLYNEUROPATHY; POLYRADICULITIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SURAL NERVE; SWEAT;

EID: 0032827462     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.5.607     Document Type: Article

References (34)

1. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:1219-50.
2. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population based cohort: the Rochester diabetic neuropathy study. Neurology 1993; 43:817-24.
3. Said G, Goulon-Goeau C, Lacroix C, et al. Severe early-onset polyneuropathy in insulin-dependant diabetes mellitus. N Engl J Med 1992;326:1257-63.
4. Said G, Goulon-Goeau C, Lacroix C, et al. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;35:559-69.
5. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995;52:1053-61.
6. Cornblath DR, Drachman DB, Griffin JW. Demyelinating motor neuropathy in patients with diabetic polyneuropathy. Ann Neurol 1987;22:1.
7. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590-6.
8. Dyck PJ. Quantitating severity of neuropathy. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993:686-97.
9. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-51.
10. Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for the diagnosis of chronic inflammmatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-18.
11. Low PA. Laboratory evaluation of autonomic failure. In: Low PA, ed. Clinical autonomic disorders: evaluation and management. Boston: Little, Brown 1997:179-208.
12. Barohn RJ, Sahenk Z, Warmolts JR, et al. The Bruns-Garland syndrome (diabetic amyotrophy) revisited 100 years later. Arch Neurol 1991;48:1130-5.
13. Dyck PJ, Litchy WJ, Kratz KM, et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838-45.
14. Said G, Slama G, Selva J. Progressive centripetal degeneration of axons in small fiber diabetic polyneuropathy. Brain 1983;106:791-807.
15. Engel WK, Prentice AF. Some polyneuropathies (Pns) in insulin-requiring adult-onset diabetes (IRAOD) can benefit remarkably from anti-dysimmune treatment. Neurology 1993;43:A255-6.
16. Walk D. Immunotherapy of neuropathies in patients with diabetes mellitus requires closer scrutiny. Arch Neurol 1996;83:590-1.
17. Stewart JD, McKelvey R, Durcan L, et al. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 1996;142:59-64.
18. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammmatory demyelinating polyradiculoneuropathy: clinical characteristics, course and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-84.
19. Simmons Z, Albers JW, Bromberg MB, et al. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyneuropathy. Neurology 1993;43:2202-2209.
20. Ingall TJ, McLeod JG, Tamura N. Autonomic function and unmyelinated fibers in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1990;13:70-6.
21. Guy RJC, Richards F, Edmonds ME, et al. Diabetic autonomic neuropathy and iritis: An association sugesting an immunological cause. BMJ 1984;209:343-5.
22. Brown FM, Brink SJ, Freeman R, et al. Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis. Diabetes 1989;38:938-41.
23. Zanone MM, Peakman M, Purewal T, et al. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type I (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:564-9.
24. Abu-Shakra SR, Cornblath DR, Avila OL, et al. Conduction block in diabetic neuropathy. Muscle Nerve 1991;14:858-62.
25. Younger DS, Rosoklija G, Hays AP, et al. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 1996;19:722-7.
26. Said G, Elgrably F, Lacroix C, et al. Painful proximal diabetic neuropathy: inflammtory nerve lesions and spontaneous favorable outcome. Ann Neurol 1997;41:762-70.
27. Pollard D, McCombe PA, Baverstock J, et al. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1986;13:123-34.
28. Cornblath DR, Griffin DE, Welch D, et al. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 1990;26:113-18.
29. Van Lis JMJ, Jennekens GI, Veldman H. Calcium deposits in the perineurium and their relation to lipid accumulation. J Neurol Sci 1979;43:367-75.
30. Kennedy WRR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990;322:1031-7.
31. Mancardi GL, Cadoni A, Zicca A, et al. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 1988;38:848-51.
32. Schróder HD, Olsson T, Solders G, et al. HLA-DR expressing cells and T-lymphocytes in sural nerve biopsies. Muscle Nerve 1988;11:864-70.
33. Vital C, Dumas P, Latinville D, et al. Relapsing inflammatory demyelinating polyneuropathy in a diabetic patient. Acta Neuropathol 1986;71:94-9.
34. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 1994;17:100-4.